Text size :

Zeni (Fid): “Screening for type 1 diabetes and celiac disease for a definitive cure”

ADNKRONOS

November 13, 2026

Rome, Nov 13. (Adnkronos Health) – “Law 130 of 2023 was fundamental for introducing screening in pediatric age for type 1 diabetes and celiac disease. The operational phase has not yet begun because the decree was only issued a few weeks ago, so everything will start in April. In the meantime, however, an important preparatory study, the D1Ce Screen study (Diabetes type 1 and Celiac disease Screen Study), has been conducted, in addition to various initiatives, including those promoted by us, such as the Italian Diabetes Foundation, which have already seen some initial screenings in the field.” This was stated by Nicola Zeni, president of Fid, participating today in the meeting promoted at the Chamber of Deputies on the eve of World Diabetes Day, which is celebrated tomorrow, November 14.

“The results are very encouraging because the presence of ketoacidosis in children at onset is drastically reduced – explains Zeni – Ketoacidosis is the real big risk of type 1 diabetes onset, as it can lead to very severe clinical conditions and also high management costs for the public health system. These are, therefore, results that we are already seeing concretely. Surely, the quality of life is constantly improving. My son – he recounts – had the onset of type 1 diabetes in 2004, and back then we were stuck with injections and blood sugar testing via finger-prick glucometer. Today we have sensors, we see blood sugar and its trend on our phones, we have insulin pumps and almost closed systems with algorithms that help with management. There is no doubt that the evolution is constantly positive. Clearly, however, the goal of the Italian Diabetes Foundation is to achieve a definitive cure. Today – he concludes – there are concrete possibilities, not exactly in the very near future, but within what are now considered reasonable times.”

Jiji Press

Related

Page TOP